AU2018231413B2 - Treatment of pruritus in horses - Google Patents

Treatment of pruritus in horses Download PDF

Info

Publication number
AU2018231413B2
AU2018231413B2 AU2018231413A AU2018231413A AU2018231413B2 AU 2018231413 B2 AU2018231413 B2 AU 2018231413B2 AU 2018231413 A AU2018231413 A AU 2018231413A AU 2018231413 A AU2018231413 A AU 2018231413A AU 2018231413 B2 AU2018231413 B2 AU 2018231413B2
Authority
AU
Australia
Prior art keywords
seq
eil
antigen
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018231413A
Other languages
English (en)
Other versions
AU2018231413A1 (en
Inventor
Martin Bachmann
Antonia FETTELSCHOSS
Victoria FETTELSCHOSS
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evax AG
Universitaet Bern
Zurich Universitaet Institut fuer Medizinische Virologie
Original Assignee
Evax AG
Universitaet Bern
Zurich Universitaet Institut fuer Medizinische Virologie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evax AG, Universitaet Bern, Zurich Universitaet Institut fuer Medizinische Virologie filed Critical Evax AG
Publication of AU2018231413A1 publication Critical patent/AU2018231413A1/en
Application granted granted Critical
Publication of AU2018231413B2 publication Critical patent/AU2018231413B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5409—IL-5

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2018231413A 2017-03-07 2018-03-07 Treatment of pruritus in horses Active AU2018231413B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17159644.8 2017-03-07
EP17159644 2017-03-07
PCT/EP2018/055644 WO2018162577A1 (en) 2017-03-07 2018-03-07 Treatment of pruritus in horses

Publications (2)

Publication Number Publication Date
AU2018231413A1 AU2018231413A1 (en) 2019-09-12
AU2018231413B2 true AU2018231413B2 (en) 2024-01-04

Family

ID=58397991

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018231413A Active AU2018231413B2 (en) 2017-03-07 2018-03-07 Treatment of pruritus in horses

Country Status (7)

Country Link
US (3) US11207390B2 (https=)
EP (1) EP3592378A1 (https=)
JP (1) JP7365240B2 (https=)
CN (1) CN110381990A (https=)
AU (1) AU2018231413B2 (https=)
CA (1) CA3054389A1 (https=)
WO (1) WO2018162577A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3093539A1 (en) 2018-03-16 2019-09-19 Zoetis Services Llc Interleukin-31 monoclonal antibodies for veterinary use
AU2019236328B2 (en) 2018-03-16 2025-10-09 Zoetis Services Llc Peptide vaccines against Interleukin-31
AU2019278596A1 (en) * 2018-05-28 2020-12-24 Evax Ag Treatment of urticaria
WO2021083766A1 (en) 2019-10-29 2021-05-06 Evax Ag Treatment of pruritus in horses
BR112023016043A2 (pt) * 2021-02-22 2023-12-05 Zoetis Services Llc Modelo de prurido induzido por il-31 de cavalo
WO2023161528A1 (en) 2022-02-28 2023-08-31 Tridem Bioscience Gmbh & Co Kg A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN
AR133291A1 (es) * 2023-07-19 2025-09-17 Inst Pasteur De Montevideo Inmunización activa para el tratamiento de la dermatitis atópica

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016062720A1 (en) * 2014-10-22 2016-04-28 Saiba Gmbh Modified virus-like particles of cmv

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
WO2003040164A2 (en) * 2001-11-07 2003-05-15 Cytos Biotechnology Ag Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
JP6987744B2 (ja) * 2015-09-08 2022-01-05 ウニヴェルズィテート チューリッヒ 虫刺され過敏症の治療
WO2018156180A1 (en) * 2017-02-24 2018-08-30 Kindred Biosciences, Inc. Anti-il31 antibodies for veterinary use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016062720A1 (en) * 2014-10-22 2016-04-28 Saiba Gmbh Modified virus-like particles of cmv

Also Published As

Publication number Publication date
EP3592378A1 (en) 2020-01-15
US20250281582A1 (en) 2025-09-11
AU2018231413A1 (en) 2019-09-12
JP2020510700A (ja) 2020-04-09
CA3054389A1 (en) 2018-09-13
US20220168405A1 (en) 2022-06-02
WO2018162577A1 (en) 2018-09-13
JP7365240B2 (ja) 2023-10-19
CN110381990A (zh) 2019-10-25
US20200016248A1 (en) 2020-01-16
US11207390B2 (en) 2021-12-28

Similar Documents

Publication Publication Date Title
US20250281582A1 (en) Treatment of pruritus in horses
US12226475B2 (en) Treatment of insect bite hypersensitivity
JP2020510700A5 (https=)
JP2025118600A (ja) じんましんの治療
KR102469478B1 (ko) 개 아토피성 피부염의 치료
CN119789863A (zh) 经修饰的cmv病毒样颗粒
JPWO2018162577A5 (https=)
KR20250115462A (ko) 알레르기 치료용 백신
WO2021083766A1 (en) Treatment of pruritus in horses
HK1252263B (en) Treatment of insect bite hypersensitivity
HK40044288A (en) Treatment of urticaria

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)